Cargando…
COVID-19 in critically ill patients in North Brabant, the Netherlands: Patient characteristics and outcomes
PURPOSE: Since the SARS-CoV-2 pandemic, countries are overwhelmed by critically ill Coronavirus disease 2019 (COVID-19) patients. As ICU capacity becomes limited we characterized critically ill COVID-19 patients in the Netherlands. METHODS: In this case series, COVID-19 patients admitted to the ICU...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414357/ https://www.ncbi.nlm.nih.gov/pubmed/32799179 http://dx.doi.org/10.1016/j.jcrc.2020.08.001 |
_version_ | 1783568960836337664 |
---|---|
author | Aleva, F.E. van Mourik, L. Broeders, M.E.A.C. Paling, A.J. de Jager, C.P.C. |
author_facet | Aleva, F.E. van Mourik, L. Broeders, M.E.A.C. Paling, A.J. de Jager, C.P.C. |
author_sort | Aleva, F.E. |
collection | PubMed |
description | PURPOSE: Since the SARS-CoV-2 pandemic, countries are overwhelmed by critically ill Coronavirus disease 2019 (COVID-19) patients. As ICU capacity becomes limited we characterized critically ill COVID-19 patients in the Netherlands. METHODS: In this case series, COVID-19 patients admitted to the ICU of the Jeroen Bosch Hospital were included from March 9 to April 7, 2020. COVID-19 was confirmed by a positive result by a RT-PCR of a specimen collected by nasopharyngeal swab. Clinical data were extracted from medical records. RESULTS: The mean age of the 50 consecutively included critically ill COVID-19 patients was 65 ± 10 years, the mean BMI was 29 ± 4.7 and 66% were men. Seventy-eight percent of patients had ≥1 comorbidity, 34% had hypertension. Ninety-six percent of patients required mechanical ventilation and 80% were ventilated in prone position. Venous thromboembolism was recognized in 36% of patients. Seventy-four percent of patients survived and were successfully discharged from the ICU, the remaining 26% died (median follow up 86 days). The length of invasive ventilation in survivors was 15 days (IQR 12–31). CONCLUSIONS: The survival rate of COVID-19 critically ill patients in our population is considerably better than previously reported. Thrombotic complications are commonly found and merit clinical attention. Trial registration number: NL2020.07.04.01 |
format | Online Article Text |
id | pubmed-7414357 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Authors. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74143572020-08-10 COVID-19 in critically ill patients in North Brabant, the Netherlands: Patient characteristics and outcomes Aleva, F.E. van Mourik, L. Broeders, M.E.A.C. Paling, A.J. de Jager, C.P.C. J Crit Care Article PURPOSE: Since the SARS-CoV-2 pandemic, countries are overwhelmed by critically ill Coronavirus disease 2019 (COVID-19) patients. As ICU capacity becomes limited we characterized critically ill COVID-19 patients in the Netherlands. METHODS: In this case series, COVID-19 patients admitted to the ICU of the Jeroen Bosch Hospital were included from March 9 to April 7, 2020. COVID-19 was confirmed by a positive result by a RT-PCR of a specimen collected by nasopharyngeal swab. Clinical data were extracted from medical records. RESULTS: The mean age of the 50 consecutively included critically ill COVID-19 patients was 65 ± 10 years, the mean BMI was 29 ± 4.7 and 66% were men. Seventy-eight percent of patients had ≥1 comorbidity, 34% had hypertension. Ninety-six percent of patients required mechanical ventilation and 80% were ventilated in prone position. Venous thromboembolism was recognized in 36% of patients. Seventy-four percent of patients survived and were successfully discharged from the ICU, the remaining 26% died (median follow up 86 days). The length of invasive ventilation in survivors was 15 days (IQR 12–31). CONCLUSIONS: The survival rate of COVID-19 critically ill patients in our population is considerably better than previously reported. Thrombotic complications are commonly found and merit clinical attention. Trial registration number: NL2020.07.04.01 The Authors. Published by Elsevier Inc. 2020-12 2020-08-08 /pmc/articles/PMC7414357/ /pubmed/32799179 http://dx.doi.org/10.1016/j.jcrc.2020.08.001 Text en © 2020 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Aleva, F.E. van Mourik, L. Broeders, M.E.A.C. Paling, A.J. de Jager, C.P.C. COVID-19 in critically ill patients in North Brabant, the Netherlands: Patient characteristics and outcomes |
title | COVID-19 in critically ill patients in North Brabant, the Netherlands: Patient characteristics and outcomes |
title_full | COVID-19 in critically ill patients in North Brabant, the Netherlands: Patient characteristics and outcomes |
title_fullStr | COVID-19 in critically ill patients in North Brabant, the Netherlands: Patient characteristics and outcomes |
title_full_unstemmed | COVID-19 in critically ill patients in North Brabant, the Netherlands: Patient characteristics and outcomes |
title_short | COVID-19 in critically ill patients in North Brabant, the Netherlands: Patient characteristics and outcomes |
title_sort | covid-19 in critically ill patients in north brabant, the netherlands: patient characteristics and outcomes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414357/ https://www.ncbi.nlm.nih.gov/pubmed/32799179 http://dx.doi.org/10.1016/j.jcrc.2020.08.001 |
work_keys_str_mv | AT alevafe covid19incriticallyillpatientsinnorthbrabantthenetherlandspatientcharacteristicsandoutcomes AT vanmourikl covid19incriticallyillpatientsinnorthbrabantthenetherlandspatientcharacteristicsandoutcomes AT broedersmeac covid19incriticallyillpatientsinnorthbrabantthenetherlandspatientcharacteristicsandoutcomes AT palingaj covid19incriticallyillpatientsinnorthbrabantthenetherlandspatientcharacteristicsandoutcomes AT dejagercpc covid19incriticallyillpatientsinnorthbrabantthenetherlandspatientcharacteristicsandoutcomes |